“A new treatment for Parkinson’s disease is undergoing clinical trials, building on successful preliminary studies with non-human primates at the University of Wisconsin–Madison. This novel approach involves transplanting dopaminergic neuronal progenitor cells into the brain, a method refined through collaboration between researchers and Aspen Neuroscience. Initial results are promising, paving the way for potential breakthroughs in the management of Parkinson’s symptoms.”

From SciTechDaily.